Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Legend Biotech (LEGN) Shares Outstanding (Diluted Average): 2019-2022

Historic Shares Outstanding (Diluted Average) for Legend Biotech (LEGN) over the last 4 years, with Dec 2022 value amounting to $318.1 million.

  • Legend Biotech's Shares Outstanding (Diluted Average) was N/A to $369.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $369.3 million, marking a year-over-year change of. This contributed to the annual value of $318.1 million for FY2022, which is 12.91% up from last year.
  • According to the latest figures from FY2022, Legend Biotech's Shares Outstanding (Diluted Average) is $318.1 million, which was up 12.91% from $281.7 million recorded in FY2021.
  • Legend Biotech's 5-year Shares Outstanding (Diluted Average) high stood at $318.1 million for FY2022, and its period low was $200.0 million during FY2019.
  • In the last 3 years, Legend Biotech's Shares Outstanding (Diluted Average) had a median value of $281.7 million in 2021 and averaged $278.7 million.
  • Data for Legend Biotech's Shares Outstanding (Diluted Average) shows a peak YoY rose of 19.21% (in 2021) over the last 5 years.
  • Yearly analysis of 4 years shows Legend Biotech's Shares Outstanding (Diluted Average) stood at $200.0 million in 2019, then rose by 18.15% to $236.3 million in 2020, then increased by 19.21% to $281.7 million in 2021, then rose by 12.91% to $318.1 million in 2022.